相关实验视频

Updated: Jul 21, 2026

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

在卵巢癌中循环瘤DNA的应用方面取得了进展

Ting Xia¹, Chenyan Fang¹, Yaqing Chen²

¹Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, 310022, Zhejiang, China.

Functional & integrative genomics

|July 21, 2023

概括

循环瘤DNA (ctDNA) 显示为卵巢癌的非侵入性生物标志物具有前途. 这篇评论强调了ctDNA的重点.

科学领域:

妇科瘤学妇科瘤学
分子诊断学分子诊断
癌症生物标志物癌症生物标志物

背景情况:

卵巢癌是全世界妇科癌症死亡的主要原因之一.
有效的生物标志物对于改善所有疾病阶段的患者预后至关重要.
从瘤细胞释放到血液中的循环瘤DNA (ctDNA) 为生物标志物发现提供了一个有希望的途径.

研究的目的:

审查最近在卵巢癌中ctDNA的应用方面的进展.
探索ctDNA作为一种非侵入性诊断和监测工具的潜力.

主要方法:

关于卵巢癌中ctDNA检测技术的当前文献的综述.
对ctDNA应用的分析,包括诊断,治疗监测和预后.
讨论诸如定量PCR和下一代测序 (NGS) 等方法.

主要成果:

ctDNA分析是一种可行的非侵入性液体活检技术,用于卵巢癌.
在早期诊断,治疗反应评估和复发检测方面,ctDNA显示出潜力.
有各种ctDNA检测方法,包括有针对性和非有针对性的NGS.

结论:

在改善卵巢癌管理方面,ctDNA具有显著的前景.
它的应用包括诊断,治疗监测和预后评估.
对ctDNA的进一步研究将提高卵巢癌患者的临床结果.

关键词:

循环瘤DNA是循环中的瘤DNA.卵巢癌是发生在卵巢中的癌症.

更多相关视频

Ovarian Cancer Detection Using Photoacoustic Flow Cytometry

Ovarian Cancer Detection Using Photoacoustic Flow Cytometry

Published on: January 17, 2020

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

相关概念视频

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...